These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12012585)

  • 1. The public health implications of HIV therapy.
    Ritsema TS
    JAAPA; 2002 Apr; 15(4):29-30, 33-4, 39. PubMed ID: 12012585
    [No Abstract]   [Full Text] [Related]  

  • 2. Issues in antiretroviral therapy: when to start?
    Boyle BA
    AIDS Read; 2001 Feb; 11(2):66-70. PubMed ID: 11279874
    [No Abstract]   [Full Text] [Related]  

  • 3. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for diagnosis and treatment of HIV/AIDS in China (2005).
    ;
    Chin Med J (Engl); 2006 Oct; 119(19):1589-608. PubMed ID: 17042972
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV therapeutics: points from the recent literature.
    Laurence J
    AIDS Read; 2003 Jul; 13(7):305, 307. PubMed ID: 12889448
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
    Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
    Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of HIV infection: a review for non-HIV-treating physicians.
    Knoll B; Lassmann B; Temesgen Z
    Int J Dermatol; 2007 Dec; 46(12):1219-28. PubMed ID: 18173512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapies. Confronting the limits of success.
    Cohen J
    Science; 2002 Jun; 296(5577):2320-4. PubMed ID: 12089422
    [No Abstract]   [Full Text] [Related]  

  • 9. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD; Keruly JC
    Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early commencement of antiretroviral therapy in HIV patients from resource-limited countries may prevent the hazards of severe immunodeficiency.
    French MA
    AIDS; 2010 Aug; 24(13):2123-4. PubMed ID: 20639727
    [No Abstract]   [Full Text] [Related]  

  • 11. Patients who want to stop their medications: treatment interruptions in HIV infection.
    Ball SC
    AIDS Read; 2003 Jul; 13(7):317-9, 324, 342. PubMed ID: 12889449
    [No Abstract]   [Full Text] [Related]  

  • 12. Infectiousness of HIV-infected men who have sex with men in the era of highly active antiretroviral therapy.
    Wilson DP; Jin F; Jansson J; Zablotska I; Grulich AE
    AIDS; 2010 Sep; 24(15):2420-1. PubMed ID: 20827060
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antiretroviral therapy in 2004].
    Jablonowski H
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():46-8, 50-1. PubMed ID: 15373049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual dysfunction and HAART.
    TreatmentUpdate; 2001 Aug; 13(4):5-7. PubMed ID: 11590980
    [No Abstract]   [Full Text] [Related]  

  • 15. Untangling the immunological implications of nadir on CD4+ cell recovery during suppressive highly active antiretroviral therapy.
    Ferraris L; Bellistri GM; Pegorer V; Tincati C; Meroni L; Galli M; Monforte Ad; Gori A; Marchetti G
    Clin Infect Dis; 2008 Jan; 46(1):149-50. PubMed ID: 18171234
    [No Abstract]   [Full Text] [Related]  

  • 16. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.
    Smith CJ; Sabin CA; Youle MS; Kinloch-de Loes S; Lampe FC; Madge S; Cropley I; Johnson MA; Phillips AN
    J Infect Dis; 2004 Nov; 190(10):1860-8. PubMed ID: 15499544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Highly active antiretroviral therapy].
    Jablonowski H
    MMW Fortschr Med; 2009 Apr; 151(18):58-61. PubMed ID: 19769079
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
    Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
    HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acute HIV-1 infection: is it coming of age?
    Kinloch-de Loes S
    J Infect Dis; 2006 Sep; 194(6):721-4. PubMed ID: 16941336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.